Spatio-temporal course of macrophage-like cell accumulation after experimental embolic stroke depending on treatment with tissue plasminogen activator and its combination with hyperbaric oxygenation

European Journal of Histochemistry

Volumn 56, Issue 2, 2012, Pages 78-89

  Michalski, D ^a   Heindl, M ^a   Kacza, J ^a   Laignel, F ^a   Kuppers Tiedt L ^a   Schneider, D ^a   Grosche, J ^a   Boltze, J ^a,b   Lohr M ^c   Hobohm, C ^a   Hartig W ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Astroglia; Experimental stroke; HBO; Macrophages; Microglia; tPA

Indexed keywords

RATTUS;

EID: 84863736888     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2012.14     Document Type: Article

References (107)

1. Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr J P, et al. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis 2008;25:268-78.
2. Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, et al. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke 2008;39:1751-8.
3. Meairs S, Wahlgren N, Dirnagl U, Lindvall O, Rothwell P, Baron JC, et al. Stroke research priorities for the next decade-A representative view of the European scientific community. Cerebrovasc Dis 2006;22:75-82.
4. Young AR, Ali C, Duretête A, Vivien D. Neuroprotection and stroke: time for a compromise. J Neurochem 2007;103:1302-9.
5. Bechmann I, Galea I, Perry VH. What is the blood-brain barrier (not)? Trends Immunol 2007;28:5-11.
6. del Zoppo GJ. Relationship of neurovascu-lar elements to neuron injury during ischemia. Cerebrovasc Dis 2009;27(Suppl.1):65-76.
7. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999;22:391-7.
8. Mergenthaler P, Dirnagl U, Meisel A. Pathophysiology of stroke: lessons from animal models. Metab Brain Dis 2004;19:151-67.
9. Danton GH, Dietrich WD. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 2003;62:127-36.
10. del Zoppo GJ. Inflammation and the neu-rovascular unit in the setting of focal cerebral ischemia. Neuroscience 2009;158:972-82.
11. Gehrmann J, Bonnekoh P, Miyazawa T, Hossmann KA, Kreutzberg GW. Immuno -cytochemical study of an early microglial activation in ischemia. J Cereb Blood Flow Metab 1992;12:257-69.
12. Lees GJ. The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J Neurol Sci 1993;114:119-22.
13. Stoll G, Jander S, Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 1998;56:149-71.
14. Tomita M, Fukuuchi Y. Leukocytes, macrophages and secondary brain damage following cerebral ischemia. Acta Neurochir Suppl 1996;66:32-9.
15. Tuttolomondo A, Di Sciacca R, Di Raimondo D, Renda C, Pinto A, Licata G. Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr Top Med Chem 2009;9:1240-60.
16. Hulette CM, Downey BT, Burger PC. Macrophage markers in diagnostic neu-ropathology. Am J Surg Pathol 1992;16:493-9.
17. Krupinski J, Kaluza J, Kumar P, Kumar S. Immunocytochemical studies of cellular reaction in human ischemic brain stroke. MAB anti-CD68 stains macrophages, astrocytes and microglial cells in infarcted area. Folia Neuropathol 1996;34:17-24.
18. Matsumoto H, Kumon Y, Watanabe H, Ohnishi T, Shudou M, Li C, et al. Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions. J Neurosci Res 2007;85:994-1009.
19. Kleinschnitz C, Bendszus M, Frank M, Solymosi L, Toyka KV, Stoll G. In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging. J Cereb Blood Flow Metab 2003;23:1356-61.
20. Wiart M, Davoust N, Pialat JB, Desestret V, Moucharrafie S, Cho TH, et al. MRI monitoring of neuroinflammation in mouse focal ischemia. Stroke 2007;38:131-7.
21. Saleh A, Schroeter M, Jonkmanns C, Hartung H P, Mödder U, Jander S. In vivo MRI of brain inflammation in human ischaemic stroke. Brain 2004;127:1670-7.
22. Orset C, Haelewyn B, Vivien K, Vivien D, Young AR. Rodent models of thromboem-bolic stroke. In: Dirnagl U, editor. Rodent Models of Stroke. New York: Humana Press c/o Springer Science + Business Media; 2010. p. 55-70.
23. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
24. Adibhatla RM, Hatcher J F. Tissue plas-minogen activator (tPA) and matrix metal-loproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol Disord Drug Targets 2008;7:243-53.
25. Burggraf D, Martens HK, Dichgans M, Hamann GF. rt-PA causes a dose-dependent increase in the extravasation of cellular and non-cellular blood elements after focal cerebral ischemia. Brain Res 2007;1164:55-62.
26. Jin R, Yang G, Li G. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis 2010;38:376-85.
27. Kelly MA, Shuaib A, Todd KG. Matrix met-alloproteinase activation and blood-brain barrier breakdown following thrombolysis. Exp Neurol 2006;200:38-49.
28. Jordán J, Segura T, Brea D, Galindo MF, Castillo J. Inflammation as therapeutic objective in stroke. Curr Pharm Des 2008;14:3549-64.
29. Rosell A, Lo EH. Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol 2008;8:82-9.
30. Giulian D, Corpuz M, Chapman S, Mansouri M, Robertson C. Reactive mononuclear phagocytes release neuro-toxins after ischemic and traumatic injury to the central nervous system. J Neurosci Res 1993;36:681-93.
31. Gregersen R, Lambertsen K, Finsen B. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 2000;20:53-65.
32. Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 2010;87:779-89.
33. Lambertsen KL, Clausen BH, Fenger C, Wulf H, Owens T, Dagnaes-Hansen F, et al. Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Neuroscience 2007;144:934-49.
34. Lindsberg PJ, Strbian D, Karjalainen-Lindsberg ML. Mast cells as early respon-ders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab 2010;30:689-702.
35. Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 2005;50:329-39.
36. Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 2005;289:H558-68.
37. Justicia C, Panés J, Solé S, Cervera A, Deulofeu R, Chamorro A, et al. Neutrophil infiltration increases matrix metallopro-teinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 2003;23:1430-40.
38. Wang G, Guo Q, Hossain M, Fazio V, Zeynalov E, Janigro D, et al. Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice. Brain Res 2009;1294:183-92.
39. Calvert JW, Cahill J, Zhang JH. Hyperbaric oxygen and cerebral physiology. Neurol Res 2007;29:132-41.
40. Jain KK. Textbook of Hyperbaric Medicine. 5th revised and updated edition. Göttingen: Hogrefe & Huber; 2009.
41. Henninger N, Küppers-Tiedt L, Sicard KM, Günther A, Schneider D, Schwab S. Neuroprotective effect of hyperbaric oxygen therapy monitored by MR-imaging after embolic stroke in rats. Exp Neurol 2006;201:316-23.
42. Schäbitz WR, Schade H, Heiland S, Kollmar R, Bardutzky J, Henninger N, et al. Neuroprotection by hyperbaric oxygena-tion after experimental focal cerebral ischemia monitored by MRI. Stroke 2004;35:1175-9.
43. Veltkamp R, Warner DS, Domoki F, Brinkhous AD, Toole J F, Busija DW. Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats. Brain Res 2000;853:68-73.
44. Sun L, Zhou W, Mueller C, Sommer C, Heiland S, Bauer AT, et al. Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia. J Cereb Blood Flow Metab 2010;30:1651-60.
45. Miljkovic-Lolic M, Silbergleit R, Fiskum G, Rosenthal RE. Neuroprotective effects of hyperbaric oxygen treatment in experimental focal cerebral ischemia are associated with reduced brain leukocyte myeloperoxidase activity. Brain Res 2003;971:90-4.
46. Atochin DN, Fisher D, Demchenko IT, Thom SR. Neutrophil sequestration and the effect of hyperbaric oxygen in a rat model of temporary middle cerebral artery occlusion. Undersea Hyperb Med 2000;27:185-90.
47. Hjelde A, Hjelstuen M, Haraldseth O, Martin D, Thom R, Brubakk O. Hyperbaric oxygen and neutrophil accumulation/tissue damage during permanent focal cerebral ischaemia in rats. Eur J Appl Physiol 2002;86:401-5.
48. Singhal AB. A review of oxygen therapy in ischemic stroke. Neurol Res 2007;29:173-83.
49. Michalski D, Härtig W, Schneider D, Hobohm C. Use of normobaric and hyper-baric oxygen in acute focal cerebral ischemia - a preclinical and clinical review. Acta Neurol Scand 2011;123:85-97.
50. Michalski D, Küppers-Tiedt L, Weise C, Laignel F, Härtig W, Raviolo M, et al. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats. Brain Res 2009;1303:161-8.
51. Zhang RL, Chopp M, Zhang ZG, Jiang Q, Ewing JR. A rat model of focal embolic cerebral ischemia. Brain Res 1997;766:83-92.
52. Härtig W, Brückner G, Holzer M, Brauer K, Bigl V. Digoxigenylated primary antibodies for sensitive dual-peroxidase labelling of neuronal markers. Histochem. Cell Biol 1995;104:467-72.
53. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007;10:1387-94.
54. Hanisch UK, van Rossum D. Microglia properties. Encyclopedia of Neuroscience 2009;5:853-9.
55. Lehrmann E, Christensen T, Zimmer J, Diemer NH, Finsen B. Microglial and macrophage reactions mark progressive changes and define the penumbra in the rat neocortex and striatum after transient middle cerebral artery occlusion. J Comp Neurol 1997;386:461-76.
56. Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, Kiefer R. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 2003;183:25-33.
57. Härtig W, Reichenbach A, Voigt C, Boltze J, Bulavina L, Schuhmann MU, et al. Triple fluorescence labelling of neuronal, glial and vascular markers revealing pathological alterations in various animal models. J Chem Neuroanat 2009;37:128-38.
58. Benjelloun N, Renolleau S, Represa A, Ben-Ari Y, Charriaut-Marlangue C. Inflammatory responses in the cerebral cortex after ischemia in the P7 neonatal rat. Stroke 1999;30:1916-23.
59. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 1998;57:1-9.
60. Weiss LM, Arber DA, Chang KL. CD68. A Review. Appl Immunohistochem 1994;2:2-8.
61. Mullen RJ, Buck CR, Smith AM. NeuN, a neuronal specific nuclear protein in vertebrates. Development 1992;116:201-11.
62. Li F, Tatlisumak T. Focal brain ischemia models in rodents. In: Tatlisumak T, Fisher M, editors. Handbook of Experimental Neurology. Cambridge: Cambridge University Press; 2006. p. 212-28.
63. Li Y, Powers C, Jiang N, Chopp M. Intact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat. J Neurol Sci 1998;156:119-32.
64. Qiao M, Meng S, Foniok T, Tuor UI. Mild cerebral hypoxia-ischemia produces a sub-acute transient inflammatory response that is less selective and prolonged after a substantial insult. Int J Dev Neurosci 2009;27:691-700.
65. Clark RK, Lee EV, Fish CJ, White RF, Price WJ, Jonak ZL, et al. Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res Bull 1993;31:565-72.
66. Kato H, Kogure K, Liu XH, Araki T, Itoyama Y. Progressive expression of immunomole-cules on activated microglia and invading leukocytes following focal cerebral ischemia in the rat. Brain Res 1996;734:203-12.
67. Jander S, Kraemer M, Schroeter M, Witte OW, Stoll G. Lymphocytic infiltration and expression of intercellular adhesion mole-cule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab 1995;15:42-51.
68. Weston RM, Jones NM, Jarrott B, Callaway JK. Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury. J Cereb Blood Flow Metab 2007;27:100-14.
69. Mena H, Cadavid D, Rushing EJ. Human cerebral infarct: a proposed histopatholog-ic classification based on 137 cases. Acta Neuropathol 2004;108:524-30.
70. Lindsberg PJ, Carpén O, Paetau A, Karjalainen-Lindsberg ML, Kaste M. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 1996;94:939-45.
71. Schroeter M, Jander S, Witte OW, Stoll G. Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol 1994;55:195-203.
72. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix met-alloproteinase-9 reduces infarct size. Stroke 1998;29:1020-30.
73. Rosell A, Cuadrado E, Ortega-Aznar A, Hernández-Guillamon M, Lo EH, Montaner J. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 2008;39:1121-6.
74. Planas AM, Solé S, Justicia C. Expression and activation of matrix metallopro-teinase-2 and -9 in rat brain after transient focal cerebral ischaemia. Neurobiol Dis 2001;8:834-46.
75. Morancho A, Rosell A, García-Bonilla L, Montaner J. Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Ann N Y Acad Sci 2010;1207: 123-33.
76. Karki K, Knight RA, Shen LH, Kapke A, Lu M, Li Y, et al. Chronic brain tissue remodeling after stroke in rat: a 1-year multi-parametric magnetic resonance imaging study. Brain Res 2010;1360:168-76.
77. Liu W, Hendren J, Qin XJ, Liu KJ. Normobaric hyperoxia reduces the neu-rovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia. Stroke 2009;40:2526-31.
78. Liu W, Hendren J, Qin XJ, Shen J, Liu KJ. Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J Neurochem 2009;108:811-20.
79. Veltkamp R, Bieber K, Wagner S, Beynon C, Siebing DA, Veltkamp C, et al. Hyperbaric oxygen reduces basal lamina degradation after transient focal cerebral ischemia in rats. Brain Res 2006;1076:231-7.
80. Buras JA, Reenstra WR. Endothelial-neu-trophil interactions during ischemia and reperfusion injury: basic mechanisms of hyperbaric oxygen. Neurol Res 2007;29:127-31.
81. Hong JP, Kwon H, Chung YK, Jung SH. The effect of hyperbaric oxygen on ischemia-reperfusion injury: an experimental study in a rat musculocutaneous flap. Ann Plast Surg 2003;51:478-87.
82. Inácio AR, Ruscher K, Leng L, Bucala R, Deierborg T. Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke. J Cereb Blood Flow Metab 2011;31:1093-106.
83. Justicia C, Martín A, Rojas S, Gironella M, Cervera A, Panés J, et al. Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. J Cereb Blood Flow Metab 2006;26:421-32.
84. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G, et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 2009;6:e1000113.
85. Madinier A, Bertrand N, Mossiat C, Prigent-Tessier A, Beley A, Marie C, et al. Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One 2009;4:e8101.
86. Smirkin A, Matsumoto H, Takahashi H, Inoue A, Tagawa M, Ohue S, et al. Iba1+/NG2+ macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain. J Cereb Blood Flow Metab 2010;30:603-15.
87. Matsumoto H, Kumon Y, Watanabe H, Ohnishi T, Shudou M, Chuai M, et al. Accumulation of macrophage-like cells expressing NG2 proteoglycan and Iba1 in ischemic core of rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 2008;28:149-63.
88. Manoonkitiwongsa PS, Jackson-Friedman C, McMillan PJ, Schultz RL, Lyden PD. Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis. J Cereb Blood Flow Metab 2001;21:1223-31.
89. Brouns R, DeDeyn P P. The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 2009;111:483-95.
90. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009;15:192-9.
91. Hobohm C, Günther A, Grosche J, Rossner S, Schneider D, Brückner G. Decomposition and long-lasting downreg-ulation of extracellular matrix in perineu-ronal nets induced by focal cerebral ischemia in rats. J Neurosci Res 2005;80:539-48.
92. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 1997;20:570-7.
93. Weinstein JR, Koerner IP, Möller T. Microglia in ischemic brain injury. Future Neurol 2010;5:227-46.
94. Halleskog C, Mulder J, Dahlström J, Mackie K, Hortobágyi T, Tanila H, et al. WNT signaling in activated microglia is proinflammatory. Glia 2011;59:119-31.
95. Lambertsen KL, Meldgaard M, Ladeby R, Finsen B. A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2005;25:119-35.
96. Nakamura Y. Regulating factors for microglial activation. Biol Pharm Bull 2002;25:945-53.
97. Denes A, Vidyasagar R, Feng J, Narvainen J, McColl BW, Kauppinen RA, et al. Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab 2007;27:1941-53.
98. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-8.
99. Nakajima K, Kohsaka S. Microglia: neuro-protective and neurotrophic cells in the central nervous system. Curr Drug Targets Cardiovasc Haematol Disord 2004;4:65-84.
100. Streit WJ. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002;40:133-9.
101. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009;40:1849-57.
102. Morioka T, Kalehua AN, Streit WJ. Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J Comp Neurol 1993;327:123-32.
103. Mabuchi T, Kitagawa K, Ohtsuki T, Kuwabara K, Yagita Y, Yanagihara T, et al. Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 2000;31:1735-43.
104. Verkhratsky A, Butte A. Glia and Diseases of the nervous system. In: Verkhratsky A, Butte A, editors. Glial Neurobiology. A Textbook. Chichester: John Wiley & Sons Ltd; 2007. p. 167-96
105. Dijkstra CD, Döpp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985;54:589-99.
106. Streit WJ. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J Histochem Cytochem 1990;38:1683-6.
107. Acarin L, Vela JM, González B, Castellano B. Demonstration of poly-N-acetyl lac-tosamine residues in ameboid and ramified microglial cells in rat brain by tomato lectin binding. J Histochem Cytochem 1994;42:1033-41.